The relationship between government research funding and the cancer burden in South Korea: implications for prioritising health research

Table 4 Differences in South Korean and global disability-adjusted life-years (DALYs) values and association with South Korean governmental research funds

Cancer		Differences in DALYs (Korean – Global)^a
Cancer		2003	2006	2009	2013
Bladder cancer		−3.38	−1.97	−0.43	1.84
Brain and nervous system cancer		− 35.57	− 37.55	− 36.54	−36.49
Breast cancer		−51.57	−37.37	−16.19	−4.63
Cervical cancer		−28.21	−34.72	−37.08	− 44.13
Colon and rectum cancer		87.63	123.68	156.63	162.55
Oesophageal cancer		−66.02	−60.20	−54.48	−52.30
Gallbladder and biliary tract cancer		118.01	117.77	119.50	114.97
Kidney cancer		2.62	7.36	12.92	19.20
Larynx cancer		−15.34	−19.58	−22.23	−24.66
Leukaemia		−40.02	−38.28	−31.21	−36.44
Lip and oral cavity cancer		−29.71	−32.06	−33.57	− 35.73
Liver cancer		452.03	425.15	397.77	331.61
Malignant skin melanoma		−13.03	−12.16	−10.96	− 10.39
Mesothelioma		−4.66	−4.09	−3.66	−3.50
Multiple myeloma		0.62	4.02	8.21	10.23
Nasopharynx cancer		−13.24	−11.70	− 11.43	−12.52
Non-Hodgkin lymphoma		−3.83	−2.64	−1.79	−0.81
Other pharynx cancer		−18.79	−18.44	− 19.56	−20.67
Ovarian cancer		−10.03	−6.79	−2.44	−0.16
Pancreatic cancer		64.18	74.62	91.20	105.41
Prostate cancer		−35.63	−28.57	−20.59	−12.46
Stomach cancer		421.41	380.21	346.85	271.43
Testicular cancer		−4.21	−4.23	−4.17	−4.01
Thyroid cancer		17.24	26.09	33.97	35.88
Tracheal, bronchus and lung cancer		165.47	179.38	189.14	180.83
Association with Korean governmental research funds	R	0.415	0.331	0.328	0.345
Association with Korean governmental research funds	P value	0.039	0.106	0.109	0.091

ISSN: 1478-4505